Kamada (KMDA) Total Current Liabilities (2012 - 2026)
Kamada (KMDA) reported Total Current Liabilities of $59.8 million for Q1 2026, up 4.78% on a YoY basis from $57.0 million in Q1 2025, and up 26.13% quarter-over-quarter from $47.4 million in Q4 2025.
Kamada (KMDA) Total Current Liabilities (2012 - 2026) Analysis & Trends
Kamada has reported Total Current Liabilities for 13 years, with the latest figure at $59.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 4.78% year-over-year to $59.8 million; the trailing twelve-month figure through Mar 2026 stood at $59.8 million (up 4.78% YoY), and the FY2025 full-year result was $47.4 million, down 4.04% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $59.8 million, up from $47.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $75.7 million in Q4 2022, with the low at $69150.0 in Q3 2022.
- Historically, Total Current Liabilities has averaged $43.5 million across 5 years, with a median of $47.4 million in 2025.
- The largest YoY upside for Total Current Liabilities was 53800.22% in 2023 against a maximum downside of 99.84% in 2023.
- Kamada's Total Current Liabilities stood at $75.7 million in 2022, then tumbled by 34.49% to $49.6 million in 2023, then fell by 0.41% to $49.4 million in 2024, then declined by 4.04% to $47.4 million in 2025, then climbed by 26.13% to $59.8 million in 2026.
- The last three Total Current Liabilities figures came in at $59.8 million (Q1 2026), $47.4 million (Q4 2025), and $47.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | 59.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.78 Mn |
| Dec 31, 2025 | 47.39 Mn |
| Sep 30, 2025 | 47.84 Mn |
| Jun 30, 2025 | 45.77 Mn |
| Mar 31, 2025 | 57.05 Mn |
| Dec 31, 2024 | 49.39 Mn |
| Sep 30, 2024 | 34.00 Mn |
| Jun 30, 2024 | 40.90 Mn |
| Mar 31, 2024 | 37.18 Mn |
| Dec 31, 2023 | 49.59 Mn |
| Sep 30, 2023 | 37.27 Mn |
| Jun 30, 2023 | 65.83 Mn |
| Mar 31, 2023 | 69,275.00 |
| Dec 31, 2022 | 75.71 Mn |
| Sep 30, 2022 | 69,150.00 |
| Jun 30, 2022 | 49.68 Mn |
| Mar 31, 2022 | 42.23 Mn |
| Dec 31, 2021 | 54.06 Mn |
| Sep 30, 2021 | 26.59 Mn |
| Jun 30, 2021 | 26.15 Mn |